SOPHARMA AD (20/2020) Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of June 2, 2020.
Report no 20/2020
- 03.06.2020, 17:54
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
SOPHARMA AD (19/2020) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of June 2, 2020.
Report no 19/2020- 03.06.2020, 11:42
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (18/2020) Notification for acquisition of own shares
Report no 18/2020- 02.06.2020, 12:53
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (17/2020) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of June 1, 2020.
Report no 17/2020- 02.06.2020, 12:42
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (16/2020) Consolidated Financial Report as at 31 March 2020
Report no 16/2020- 01.06.2020, 16:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (14/2020) Sales revenues for April 2020
Report no 14/2020- 05.05.2020, 19:08
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (12/2020) Consolidated Audited Financial Report according to IFRS as at 31 December 2019
Report no 12/2020- 04.05.2020, 22:37
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (11/2020) Publishing of the Consolidated Audited Financial Statements for 2019 made public in the terms envisaged in §45, item 2 of the TAP of the Law for the measures and actions under extraordinary circumstances
Report no 11/2020- 29.04.2020, 16:56
- Kategoria: Biznes i finanse
- Źródło: ESPI
